Text messages to support opioid medication adherence
Part of Mental health, Pain clinical trials.
This study tests whether daily supportive text messages help people stay on track with their methadone or buprenorphine treatment for opioid use disorder. It is designed for adults who recently started or resumed this medication and have a cellphone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have a cellphone that can receive text messages.
- You have internet access to fill out surveys online.
- You are willing to follow the study plan for the full length of the study.
- You started or restarted taking daily methadone or buprenorphine (like Suboxone/Subutex) within the last 6 months.
- You can understand the study details and agree to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if text messages with meditation tips and medication reminders can help people with chronic pain stick to their treatment for opioid use. If you recently started or restarted methadone or buprenorphine, this might be for you.
This trial tests a mindfulness-based app (Mindful Journey) to help people with both opioid use disorder and chronic pain. You'll use the app daily for a short time to see if it reduces pain and supports your recovery.
This Phase 3 study tests whether using smartphones can help people with opioid-use disorder stick with treatment and recover more successfully. It focuses on people starting or already in treatment using methadone or buprenorphine, with support delivered through the study app or messages.
This study tests if a mobile mindfulness training app can help people who are receiving medication treatment for opioid use disorder. It is for people with a history of childhood trauma who are stable on their medication.
This study tests if a smartphone app can help people taking medications for opioid use disorder and who also have alcohol use disorder. You will use the app for 6 months and provide feedback through surveys and saliva drug tests.
This study tests a behavioral support program designed to help people newly starting buprenorphine treatment for opioid use disorder stay engaged with their care. If you've recently started buprenorphine or just been released from incarceration and are beginning treatment, this trial may help you maintain consistent medication use and reduce the risk of relapse.
Hear when a new Chronic pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.